FDA outlines process for recognizing standards for regenerative medicines
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)North AmericaProduct developmentRegulatory Intelligence/Policy